Skip to Content

We invite you to try out our new beta eCFR site at https://ecfr.federalregister.gov. We’ve made big changes to make the eCFR easier to use. Be sure to leave feedback using the 'Feedback' button on the bottom right of each page!

Notice

Requests for Proposals for Insulin Reimportation and Personal Prescription Drug Importation

Document Details

Information about this document as published in the Federal Register.

Document Statistics
Document page views are updated periodically throughout the day and are cumulative counts for this document. Counts are subject to sampling, reprocessing and revision (up or down) throughout the day.
Enhanced Content

Relevant information about this document from Regulations.gov provides additional context. This information is not part of the official Federal Register document.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

AGENCY:

Department of Health and Human Services (HHS), Food and Drug Administration (FDA).

ACTION:

Notice; requests for proposals.

SUMMARY:

On September 24, 2020, the Department issued two requests for proposals for the reimportation of insulin and the personal importation of prescription drugs on its website. The Department is issuing this Notice to include a revised version of the September 24, 2020 proposals in the Federal Register.

DATES:

Proposals submitted in response to the requests for proposals shall be accepted and reviewed on a rolling basis, and until further notice.

ADDRESSES:

Responses to the requests for proposals should be submitted to import@hhs.gov.

Start Further Info

FOR FURTHER INFORMATION CONTACT:

Nick Uehlecke, 200 Independence Ave SW, Washington, DC 20201; or by email at import@hhs.gov; or by telephone at 1-877-696-6775.

End Further Info End Preamble Start Supplemental Information Start Printed Page 6344

SUPPLEMENTARY INFORMATION:

On September 24, 2020, the Department issued two requests for proposals for the reimportation of insulin and the personal importation of prescription drugs on its website. The proposals were issued consistent with FDA's authorities under sections 801 and 804 of the Food, Drug, and Cosmetic Act, 21 U.S.C. 381, 384. The Department is issuing this Notice to include revised versions of these proposals in the Federal Register.

Start Signature

Dated: January 13, 2021.

Alex M. Azar II,

Secretary, Department of Health and Human Services.

End Signature End Supplemental Information

[FR Doc. 2021-01125 Filed 1-19-21; 8:45 am]

BILLING CODE 4150-26-P